L.A. Times -
7 May 2014 18:32

Victims of a fungal meningitis outbreak traced to a tainted steroid produced by a Massachusetts compounding pharmacy will be compensated from a $100-million fund created as part of the legal settlement stemming from the 2012 incident. The settlement was filed this week in federal bankruptcy...
Share this Article